Skip to main content
Ana Barac on Muck Rack

Ana Barac

As seen in: Color Research & Application, Wiley, Wiley Online Library, Patient Education and Counseling, heart, JAMA Oncology, AHA/ASA Journals, Healio, Journal of Clinical Oncology, JACC (Journal of the American College of Cardiology)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ana

Contact Ana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association

|
By Ana Barac, Avirup Guha
| Journal of Clinical Oncology Verified
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
Open in Who Shared Issue with article?

2026 Dyslipidemia Guideline-at-a-Glance:

|
By Barbara S. Wiggins, Ana Barac, Catherine P. Benziger
| JACC (Journal of the American College of Cardiology)
Introduction The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia 1 (ACC/AHA/Multisociety Dyslipidemia Guideline) focuses on the implementation of new therapies and the evaluation of associated risk for individuals with dyslipidemia in primary and secondary prevention settings.
Open in Who Shared Issue with article?

Risk Prediction Model for Development of Heart Failure or Cardiomyopathy After Breast Cancer Treatment

|
By Ana Barac
| JAMA Oncology Verified
Key Points Question Can the 10-year risk of heart failure or cardiomyopathy (HF/CM) in adult women diagnosed with early-stage breast cancer (BC) be predicted based on the cancer treatment and preexisting cardiovascular risk factors?
Open in Who Shared Issue with article?
See all 25 articles